nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2022, 11, v.41;No.421 1215-1218+1226
王旭从肝脾论治甲状腺癌术后经验
基金项目(Foundation): 国家自然科学基金项目(编号:81973796)
邮箱(Email):
DOI: 10.16295/j.cnki.0257-358x.2022.11.013
摘要:

王旭教授认为甲状腺癌术后患者的病机总属本虚标实,基本病机为肝郁气滞、脾失健运,在疾病发展过程中可兼夹血瘀、痰凝,但肝气乘脾的基本病机贯穿始终,病久可累及心、肺、肾。治疗上以调和肝脾为核心,兼顾他脏,并将甲状腺癌术后分为3期,认为疾病初起主要涉及肝脾,疾病中期累及心肺,疾病后期脾病及肾,且有久病入络之虞,故在不同时期根据病位所在,辨证论治,并中西贯通。

Abstract:

Professor WANG Xu holds that the disease mechanism of thyroid cancer after surgery are mainly deficient root and excessive branch. The primary disease mechanism are liver qi stagnation and spleen failing to transport,and in the course of disease development,there are often with blood stasis and phlegm coagulation.The primary disease mechanism liver qi attacking spleen is present in the whole course,and heart,lung and kidney are usually involved finally. On treatment,the core is to harmonize liver and spleen,supplemented by treating other Zang orangs. The thyroid cancer after surgery could be divided into three stages. In the early stage it mainly involves liver and spleen,in the middle stage involves heart and lung,and in the late stage involves kidney,as well as affecting collaterals. Therefore,according to different stage and disease location,treatment based on syndrome differentiation should be conducted in combination with western medicine.

参考文献

[1] KIM J,GOSNELL J E,ROMAN S A. Geographic influences in the global rise of thyroid cancer[J]. Nat Rev Endocrinol,2020,16(1):17-29.

[2] MITCHELL A L,GANDHI A,SCOTT-COOMBES D,et al.Management of thyroid cancer:United Kingdom national multidisciplinary guidelines[J]. J Laryngol Otol,2016,130(S2):S150-S160.

[3]中华人民共和国国家卫生健康委员会.甲状腺癌诊疗规范(2018年版)[J].中华普通外科学文献(电子版),2019,13(1):1-15.

[4]彭文静,周小军.中医古籍中头颈部恶性肿瘤患者体质研究[J].中医学报,2012,27(10):1236-1238.

[5]张慧君,徐筱玮.甲状腺癌术后病人中医体质辨识研究[J].世界最新医学信息文摘,2019,19(59):286-287.

[6]褚美玲,徐晋.中医药在甲状腺癌术后中的应用[J].中国民族民间医药,2020,29(5):35-37.

[7]欧阳文奇,陈继东,向楠,等.陈如泉辨证分型治疗乳头状甲状腺癌术后[J].中医药临床杂志,2020,32(1):24-26.

[8]赵勇,徐文华,陈如泉.陈如泉运用益气养阴扶正法治疗甲状腺癌术后经验[J].湖北中医杂志,2013,35(11):24-25.

[9]刘瑞,花宝金.调理脾胃法防治肿瘤的理论基础及分子机制[J].中医杂志,2013,54(18):1608-1612.

[10] FERRARI S M,FALLAHI P,GALDIERO M R,et al.Immune and inflammatory cells in thyroid cancer microenvironment[J]. Int J Mol Sci,2019,20(18):E4413.

[11]王加锋,展照双.阴火论探微及临证应用[J].山东中医杂志,2016,35(3):193-195.

[12]杨锦强,杨念云,吴啟南.佩兰的化学成分[J].中国药业,2017,26(21):4-6.

[13]贾金平,万冬桂.石菖蒲在肿瘤治疗中的应用浅谈[J].中国医药科学,2018,8(20):27-29.

[14]田英雪,王镁.从脾论治甲状腺疾病研究简况[J].实用中医内科杂志,2013,27(20):84-86.

[15]任志雄,李光善,倪青.林兰教授从中医新释甲状腺疾病[J].世界中医药,2013,8(1):96-98.

[16]陈培浪,刘锦.甲状腺素对尿毒症患者心功能的影响[J].临床医学,2017,37(4):56-58.

[17]王旭,朱垚,陆明.周仲瑛“瘀热致消”学术思想探究[J].中医杂志,2009,50(3):206-207.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2022.11.013

中图分类号:R249;R273

引用信息:

[1]刘晓歌,王旭.王旭从肝脾论治甲状腺癌术后经验[J],2022,41(11):1215-1218+1226.DOI:10.16295/j.cnki.0257-358x.2022.11.013.

基金信息:

国家自然科学基金项目(编号:81973796)

检 索 高级检索